Mitochondrial methylenetetrahydrofolate dehydrogenase (MTHFD2) overexpression is associated with tumor cell proliferation and is a novel target for drug development
Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK
Rights and permissions About this article Cite this article Hassan, O.K., Hayawi, M.A., Shareef, A.S
CVS Caremark drops coverage of popular weight loss drug Medical experts warn insurance decisions are overriding doctor recommendations and disrupting patient progress CVS Caremark, one of the three major pharmacy benefit managers (PBM) in the U.S., stopped coverage for Eli Lilly's popular weight-loss drug Zepbound, blaming drugs like it for driving up overall plan costs
Health risks associated with contamination of groundwater by abandoned mines near Twisp in Okanogan County, Washington, USA
STA-320) according to the manufacturers instructions